We are pleased to welcome Dr. Bairey Merz to our Board and look forward to the contributions she will make, said
An international figure in preventive cardiology and heart disease in women, Dr. Bairey Merz previously served on nonprofit boards including the
"I am honored to join iRhythm’s Board of Directors," said Dr. Bairey Merz. Throughout my career I’ve embraced innovation, and iRhythm is bringing exciting new technology to cardiology that clearly benefits both providers and patients. I look forward to leveraging my expertise and contributing to the company’s clinical strategy to further iRhythm’s leadership in cardiac monitoring.
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
Investor Relations Contact: